208 related articles for article (PubMed ID: 24998852)
1. Physical and functional interaction of the TPL2 kinase with nucleophosmin.
Kanellis DC; Bursac S; Tsichlis PN; Volarevic S; Eliopoulos AG
Oncogene; 2015 May; 34(19):2516-26. PubMed ID: 24998852
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
4. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
Brady SN; Yu Y; Maggi LB; Weber JD
Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
[TBL] [Abstract][Full Text] [Related]
5. EBP2, a novel NPM-ALK-interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53.
Uchihara Y; Tago K; Tamura H; Funakoshi-Tago M
Mol Oncol; 2021 Jan; 15(1):167-194. PubMed ID: 33040459
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
7. Cell adhesion tunes inflammatory TPL2 kinase signal transduction.
Vougioukalaki M; Georgila K; Athanasiadis EI; Eliopoulos AG
Cell Mol Life Sci; 2022 Feb; 79(3):156. PubMed ID: 35218437
[TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
[TBL] [Abstract][Full Text] [Related]
9. SIRT7-dependent deacetylation of NPM promotes p53 stabilization following UV-induced genotoxic stress.
Ianni A; Kumari P; Tarighi S; Simonet NG; Popescu D; Guenther S; Hölper S; Schmidt A; Smolka C; Yue S; Krüger M; Fiorillo C; Vaquero A; Bober E; Braun T
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495326
[TBL] [Abstract][Full Text] [Related]
10. TPL2 kinase is a suppressor of lung carcinogenesis.
Gkirtzimanaki K; Gkouskou KK; Oleksiewicz U; Nikolaidis G; Vyrla D; Liontos M; Pelekanou V; Kanellis DC; Evangelou K; Stathopoulos EN; Field JK; Tsichlis PN; Gorgoulis V; Liloglou T; Eliopoulos AG
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1470-9. PubMed ID: 23533274
[TBL] [Abstract][Full Text] [Related]
11. Tpl2 is a key mediator of arsenite-induced signal transduction.
Lee KM; Lee KW; Bode AM; Lee HJ; Dong Z
Cancer Res; 2009 Oct; 69(20):8043-9. PubMed ID: 19808956
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration.
Hatziapostolou M; Koukos G; Polytarchou C; Kottakis F; Serebrennikova O; Kuliopulos A; Tsichlis PN
Sci Signal; 2011 Aug; 4(187):ra55. PubMed ID: 21868363
[TBL] [Abstract][Full Text] [Related]
13. AKT regulates NPM dependent ARF localization and p53mut stability in tumors.
Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
[TBL] [Abstract][Full Text] [Related]
14. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
[TBL] [Abstract][Full Text] [Related]
15. IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.
Handoyo H; Stafford MJ; McManus E; Baltzis D; Peggie M; Cohen P
Biochem J; 2009 Oct; 424(1):109-18. PubMed ID: 19754427
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin sets a threshold for p53 response to UV radiation.
Maiguel DA; Jones L; Chakravarty D; Yang C; Carrier F
Mol Cell Biol; 2004 May; 24(9):3703-11. PubMed ID: 15082766
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HDM2 and activation of p53 by ribosomal protein L23.
Jin A; Itahana K; O'Keefe K; Zhang Y
Mol Cell Biol; 2004 Sep; 24(17):7669-80. PubMed ID: 15314174
[TBL] [Abstract][Full Text] [Related]
18. Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response.
Kurki S; Peltonen K; Laiho M
Cell Cycle; 2004 Aug; 3(8):976-9. PubMed ID: 15254398
[TBL] [Abstract][Full Text] [Related]
19. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
20. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
Phelps M; Phillips A; Darley M; Blaydes JP
J Biol Chem; 2005 Apr; 280(17):16651-8. PubMed ID: 15723837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]